白内障术后人工晶状体混浊  

Intraocular lens opacification after cataract surgery

作　　者：李兆春[1] 姚克[1] 徐雯[1] 

机构地区：[1]浙江大学医学院附属二院眼科中心浙江省重要致盲眼病防治技术研究重点实验室,杭州310009

出　　处：《国际眼科纵览》2013年第2期112-116,共5页International Review of Ophthalmology

基　　金：浙江省重点创新团队项目（2009R50039）;浙江省重点实验室项目（2011E10006）

摘　　要：白内障术后人工晶状体（intraocular lens，IOL）混浊是近来研究的热点之一。亲水性IOL混浊平均发生率不同文献统计差异较大，国内平均发病年龄小于国外。PMMA、硅凝胶和疏水性丙烯酸酯IOL混浊的发生率均较亲水性为低。女性发生率高于男性。糖尿病和青光眼是与IOL混浊关系最大的两种疾病。对比敏感度检查对早期诊断IOL混浊具有重要价值。IOL混浊易被误诊为其他疾病，尤其是后发障，应引起高度重视。IOL置换术是目前治疗IOL混浊的主要手段。手术时机需根据患者视力、年龄等情况具体掌握。置换术后效果明显，严重并发症发生率均较低。二次植入IOL优先选择非亲水性IOL。Intraocular lens （IOL） opacification after cataract surgery is one of the recent research hotspots. The rate of hydrophilic IOL opacification is variable in the literatures. The average age of onset in domestic is younger than in overseas. The rate of PMMA, silicone or hydrophobic acrylic IOL opacification is far lower than hydrophilic IOL. The rate of opacification is higher in women than in men. Diabetes and glaucoma are thought to be the most important diseases associated with IOL opacification. Contrast sensitivity is an important test for early diagnosis of IOL opacification. IOL opacification is easily misdiagnosed with other diseases, especially posterior capsular opacification. IOL replacement is the main treatment of IOL opacification. The timing of surgery depends on patient＇s situation including vision and age. Postoperative results are obvious and severe complications are rare. The second IOL should not be a hydrophilic acrylic lens.

关 键 词：白内障 外科学 人工晶状体混浊 人工晶状体置换术 

分 类 号：R779.66[医药卫生—眼科]